{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:49:39Z","timestamp":1783010979365,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00520-025-09528-0","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:43:50Z","timestamp":1747770230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proton pump inhibition to prevent delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy: a phase II, randomised double-blind crossover trial (PantoCIN)"],"prefix":"10.1007","volume":"33","author":[{"given":"Navin","family":"Wewala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Sharples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Benge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheridan","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Kuper-Hommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth","family":"Hari Dass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbey","family":"Wrigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"8","key":"9528_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/bjc.1997.507","volume":"76","author":"M de Boer-Dennert","year":"1997","unstructured":"de Boer-Dennert M, de Wit R, Schmitz PI et al (1997) Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 76(8):1055\u20131061. https:\/\/doi.org\/10.1038\/bjc.1997.507","journal-title":"Br J Cancer"},{"issue":"27","key":"9528_CR2","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","volume":"24","author":"B Bloechl-Daum","year":"2006","unstructured":"Bloechl-Daum B, Deuson RR, Mavros P et al (2006) Delayed nausea and vomiting continue to reduce patients\u2019 quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 24(27):4472\u20134478. https:\/\/doi.org\/10.1200\/JCO.2006.05.6382","journal-title":"J Clin Oncol"},{"issue":"2","key":"9528_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1515725","volume":"375","author":"RM Navari","year":"2016","unstructured":"Navari RM, Qin R, Ruddy KJ et al (2016) Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med 375(2):134\u2013142. https:\/\/doi.org\/10.1056\/NEJMoa1515725","journal-title":"N Engl J Med"},{"issue":"1","key":"9528_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12282-019-01001-1","volume":"27","author":"Y Naito","year":"2020","unstructured":"Naito Y, Kai Y, Ishikawa T et al (2020) Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study. Breast Cancer 27(1):122\u2013128. https:\/\/doi.org\/10.1007\/s12282-019-01001-1","journal-title":"Breast Cancer"},{"issue":"2","key":"9528_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1200\/JCO.2013.51.4547","volume":"32","author":"F Roila","year":"2014","unstructured":"Roila F, Ruggeri B, Ballatori E et al (2014) Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: a randomized double-blind study. J Clin Oncol 32(2):101\u2013106. https:\/\/doi.org\/10.1200\/JCO.2013.51.4547","journal-title":"J Clin Oncol"},{"issue":"10","key":"9528_CR6","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cncr.20230","volume":"100","author":"SM Grunberg","year":"2004","unstructured":"Grunberg SM, Deuson RR, Mavros P et al (2004) Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer 100(10):2261\u20132268. https:\/\/doi.org\/10.1002\/cncr.20230","journal-title":"Cancer"},{"issue":"suppl 5","key":"9528_CR7","doi-asserted-by":"publisher","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","volume":"27","author":"F Roila","year":"2016","unstructured":"Roila F, Molassiotis A, Herrstedt J et al (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 27(suppl 5):v119\u2013v133. https:\/\/doi.org\/10.1093\/annonc\/mdw270","journal-title":"Ann Oncol"},{"issue":"11","key":"9528_CR8","first-page":"4951","volume":"33","author":"G Riezzo","year":"2013","unstructured":"Riezzo G, Clemente C, Linsalata M et al (2013) Gut peptide profile and chemotherapy-associated dyspepsia syndrome in patients with breast cancer undergoing FEC60 chemotherapy. Anticancer Res 33(11):4951\u20134957","journal-title":"Anticancer Res"},{"issue":"Suppl 5","key":"9528_CR9","doi-asserted-by":"publisher","first-page":"v139","DOI":"10.1093\/annonc\/mdv202","volume":"26","author":"DE Peterson","year":"2015","unstructured":"Peterson DE, Boers-Doets CB, Bensadoun RJ et al (2015) Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v139\u2013v151. https:\/\/doi.org\/10.1093\/annonc\/mdv202","journal-title":"Ann Oncol"},{"issue":"7","key":"9528_CR10","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/(sici)1097-0142(19961001)78:7<1477::aid-cncr15>3.0.co;2-x","volume":"78","author":"S Sartori","year":"1996","unstructured":"Sartori S, Trevisani L, Nielsen I et al (1996) Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study. Cancer 78(7):1477\u20131482. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19961001)78:7<1477::aid-cncr15>3.0.co;2-x","journal-title":"Cancer"},{"key":"9528_CR11","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Antiemesis (Version 2.2023). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf. Accessed 12 Aug 2023"},{"issue":"1","key":"9528_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","volume":"14","author":"C Scarpignato","year":"2016","unstructured":"Scarpignato C, Gatta L, Zullo A et al (2016) Effective and safe proton pump inhibitor therapy in acid-related diseases - a position paper addressing benefits and potential harms of acid suppression. BMC Med 14(1):179. https:\/\/doi.org\/10.1186\/s12916-016-0718-z","journal-title":"BMC Med"},{"issue":"8","key":"9528_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1046\/j.1365-2036.2000.00788.x","volume":"14","author":"CA Stedman","year":"2000","unstructured":"Stedman CA, Barclay ML (2000) Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 14(8):963\u2013978. https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00788.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"9528_CR14","first-page":"203","volume":"69","author":"UA Meyer","year":"1996","unstructured":"Meyer UA (1996) Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions. Yale J Biol Med 69(3):203\u2013209","journal-title":"Yale J Biol Med"},{"issue":"6","key":"9528_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","volume":"10","author":"JM Shin","year":"2008","unstructured":"Shin JM, Sachs G (2008) Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep 10(6):528\u2013534. https:\/\/doi.org\/10.1007\/s11894-008-0098-4","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"9528_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpainsymman.2006.10.018","volume":"34","author":"A Molassiotis","year":"2007","unstructured":"Molassiotis A, Coventry PA, Stricker CT et al (2007) Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J Pain Symptom Manage 34(2):148\u2013159. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.10.018","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"9528_CR17","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00535-004-1417-7","volume":"39","author":"M Kusano","year":"2004","unstructured":"Kusano M, Shimoyama Y, Sugimoto S et al (2004) Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 39(9):888\u2013891. https:\/\/doi.org\/10.1007\/s00535-004-1417-7","journal-title":"J Gastroenterol"},{"key":"9528_CR18","unstructured":"R Core Team (2022) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. https:\/\/www.R-project.org\/.\u00a0Accessed 11 Jul 2022"},{"issue":"1","key":"9528_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, Maechler M, Bolker B, Walker S (2015) Fitting linear mixed-effects models usinG lme4. J Stat Softw 67(1):1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01","journal-title":"J Stat Softw"},{"key":"9528_CR20","first-page":"350","volume-title":"Categorical data analysis","author":"A Agresti","year":"1990","unstructured":"Agresti A (1990) Categorical data analysis. Wiley, New York, pp 350\u2013354"},{"issue":"35","key":"9528_CR21","doi-asserted-by":"publisher","first-page":"58801","DOI":"10.18632\/oncotarget.18522","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Liu C, Wang J et al (2017) Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer. Oncotarget 8(35):58801\u201358808. https:\/\/doi.org\/10.18632\/oncotarget.18522. (Published 2017 Jun 16)","journal-title":"Oncotarget"},{"key":"9528_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14238\/pi58.1.2018.42-7","volume":"58","author":"P Simbolon","year":"2018","unstructured":"Simbolon P, Nafianti S, Sianturi P et al (2018) The addition of omeprazole to ondansetron for treating chemotherapy-induced nausea and vomiting in pediatric cancer patients. Paediatr Indones 58:42\u201347","journal-title":"Paediatr Indones"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09528-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09528-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09528-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:03:21Z","timestamp":1749492201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09528-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9528"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09528-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The protocol and all amendments were approved by a New Zealand Health and Disabilities Ethics Committee at all participating centres.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"484"}}